Peter Salzmann - 30 Aug 2022 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Chief Executive Officer, Director
Signature: /s/ Eva Renee Barnett, attorney-in-fact for Peter Salzmann
Issuer symbol: IMVT
Transactions as of: 30 Aug 2022
Net transactions value: -$9,585
Form type: 4
Filing time: 01 Sep 2022, 07:36:15 UTC
Previous filing: 19 Aug 2022
Next filing: 29 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Sale	$9,585	-1,644	-0.16%	$5.83	1,002,351	30 Aug 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,761 of these RSUs vested on August 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Content

On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,761 of these RSUs vested on August 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.